DR info

臨床試験数 : 12 / 薬物数 : 14 - (DrugBank : 5) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 11

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

6R-BH4
   AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
      2007   -   EUCTR2007-004370-55-IT   Italy;
ARICEPT 5*28 CPR
   EISAI LTD UK
      2005   -   EUCTR2004-001162-40-IT   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
Antiplatelets
   S. Andrea Hospital
      2011   Phase 2   NCT01361763   Italy;
Aricept
   Eisai Limited
      2005   Phase 2   NCT00103948   Australia;Canada;Finland;France;Germany;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
   Eisai Ltd
      2005   Phase 2   EUCTR2004-001162-40-GB   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   Phase 2   EUCTR2004-001162-40-FI   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   Phase 2   EUCTR2004-001162-40-ES   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-001162-40-SE   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      -   -   EUCTR2004-001162-40-DE   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
Cilostazol
   Mayo Clinic
      2021   Phase 1/Phase 2   NCT04753970   United States;
Dabigatran
   S. Andrea Hospital
      2011   Phase 2   NCT01361763   Italy;
Donepezil
   EISAI LTD UK
      2005   -   EUCTR2004-001162-40-IT   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
Donepezil hydrochloride
   Eisai Ltd
      2005   Phase 2   EUCTR2004-001162-40-GB   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   Phase 2   EUCTR2004-001162-40-FI   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   Phase 2   EUCTR2004-001162-40-ES   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-001162-40-SE   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      -   -   EUCTR2004-001162-40-DE   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
E2020
   Eisai Ltd
      2005   Phase 2   EUCTR2004-001162-40-GB   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   Phase 2   EUCTR2004-001162-40-FI   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   Phase 2   EUCTR2004-001162-40-ES   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      2005   -   EUCTR2004-001162-40-SE   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
      -   -   EUCTR2004-001162-40-DE   Finland;Germany;Italy;Spain;Sweden;United Kingdom;
Fremanezumab
   Mayo Clinic
      2021   Phase 2   NCT04334408   United States;
HOV-12020 (Palm tocotrienols complex)
   Hovid Berhad
      2020   Phase 2   NCT04658823   France;
Phenoptin
   AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
      2007   -   EUCTR2007-004370-55-IT   Italy;
Sapropterin
   AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
      2007   -   EUCTR2007-004370-55-IT   Italy;